These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35096557)

  • 1. Molecular Characterization and Prognostication of Large Cell Neuroendocrine Carcinoma and Large Cell Carcinoma.
    Chen Y; Cui X; Wang D; Xia G; Xing M; Cheng L; Sheng L; Du X
    Front Oncol; 2021; 11():664397. PubMed ID: 35096557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.
    Li F; Yang Y; Xu Y; Li K; Song L; Xue Y; Dong D
    Medicine (Baltimore); 2023 Jan; 102(4):e32781. PubMed ID: 36705391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcomes of patients with different subtypes of large cell carcinoma of the lung.
    Sun YH; Lin SW; Hsieh CC; Yeh YC; Tu CC; Chen KJ
    Ann Thorac Surg; 2014 Sep; 98(3):1013-9. PubMed ID: 25085555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma.
    Saghaeiannejad Esfahani H; Vela CM; Chauhan A
    Front Oncol; 2021; 11():653153. PubMed ID: 34141612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary large cell carcinoma with neuroendocrine morphology shows genetic similarity to large cell neuroendocrine carcinoma.
    Liang Z; Wang W; Hu Q; Zhou P; Zhang Y; Tang Y; Wu Q; Fu Y; Li X; Shao Y; Jiang L
    Diagn Pathol; 2022 Feb; 17(1):26. PubMed ID: 35144629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of genomic landscapes of large cell neuroendocrine carcinoma, small cell lung carcinoma, and large cell carcinoma.
    Zhou Z; Zhu L; Niu X; Shen S; Zhao Y; Zhang J; Ye J; Han-Zhang H; Liu J; Liu C; Lu S
    Thorac Cancer; 2019 Apr; 10(4):839-847. PubMed ID: 30793508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile.
    Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; ; Ruland A; Speel EJM; Dingemans AMC
    Lung Cancer; 2019 Dec; 138():102-108. PubMed ID: 31678831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and prognostic value of PD-L1 expression in molecular subtypes of metastatic large cell neuroendocrine carcinoma (LCNEC).
    Hermans BCM; Derks JL; Thunnissen E; van Suylen RJ; den Bakker MA; Groen HJM; Smit EF; Damhuis RA; van den Broek EC; Stallinga CM; Roemen GM; Speel EJM; Dingemans AC;
    Lung Cancer; 2019 Apr; 130():179-186. PubMed ID: 30885341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma-like and Non-Small Cell Carcinoma-like Subsets.
    Rekhtman N; Pietanza MC; Hellmann MD; Naidoo J; Arora A; Won H; Halpenny DF; Wang H; Tian SK; Litvak AM; Paik PK; Drilon AE; Socci N; Poirier JT; Shen R; Berger MF; Moreira AL; Travis WD; Rudin CM; Ladanyi M
    Clin Cancer Res; 2016 Jul; 22(14):3618-29. PubMed ID: 26960398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High grade neuroendocrine lung tumors: pathological characteristics, surgical management and prognostic implications.
    Grand B; Cazes A; Mordant P; Foucault C; Dujon A; Guillevin EF; Barthes FLP; Riquet M
    Lung Cancer; 2013 Sep; 81(3):404-409. PubMed ID: 23769675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
    Zhou F; Hou L; Ding T; Song Q; Chen X; Su C; Li W; Gao G; Ren S; Wu F; Fan J; Wu C; Zhang J; Zhou C
    Lung Cancer; 2018 Feb; 116():30-37. PubMed ID: 29413048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study.
    Song L; Zhou F; Xu T; Zeng L; Xia Q; Wang Z; Deng L; Li Y; Qin H; Yan H; Huang Z; Mi J; Xu Q; Yang N; Zhou C; Zhang Y
    BMC Cancer; 2023 May; 23(1):443. PubMed ID: 37189075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a nomogram for predicting the overall survival of patients with lung large cell neuroendocrine carcinoma.
    Xi J; Zhao M; Zheng Y; Liang J; Hu Z; Huang Y; Yang Y; Zhan C; Jiang W; Lu T; Guo W; Wang Q
    Transl Cancer Res; 2020 Aug; 9(8):4943-4957. PubMed ID: 35117856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.
    Massoni Neto LM; Bianchi CP; Ab'Saber AM; Parra ER; Takagaki T; Pereira JC; Soares FA; Leite K; Capelozzi VL
    Braz J Med Biol Res; 2007 Aug; 40(8):1045-53. PubMed ID: 17665040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different Characteristics and Survival between Surgically Resected Pure and Combined Pulmonary Large Cell Neuroendocrine Carcinoma.
    Wang Y; Chen Y; Yang Z; Qian F; Hu M; Lu J; Zhang Y; Zhang W; Wang K; Han B
    Ann Surg Oncol; 2022 Sep; 29(9):5666-5678. PubMed ID: 35543906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.
    Hermans BCM; Derks JL; Hillen LM; van der Baan I; van den Broek EC; von der Thüsen JH; van Suylen RJ; Atmodimedjo PN; den Toom TD; Coumans-Stallinga C; Timens W; Dinjens WNM; Dubbink HJ; Speel EM; Dingemans AC;
    Int J Cancer; 2022 Mar; 150(5):802-815. PubMed ID: 34674268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Study of Pulmonary Combined Large-Cell Neuroendocrine Carcinoma and Combined Small-Cell Carcinoma in Surgically Resected High-Grade Neuroendocrine Tumors of the Lung.
    Wang Y; Qian F; Chen Y; Yang Z; Hu M; Lu J; Zhang Y; Zhang W; Cheng L; Han B
    Front Oncol; 2021; 11():714549. PubMed ID: 34631540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on large cell neuroendocrine carcinoma.
    Hiroshima K; Mino-Kenudson M
    Transl Lung Cancer Res; 2017 Oct; 6(5):530-539. PubMed ID: 29114469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome characterization of large-cell lung carcinoma: A comparative analysis based on the histological classification.
    Wu X; Yin J; Deng Y; Zu Y
    Front Genet; 2022; 13():1070048. PubMed ID: 36685819
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular Pathology of Pulmonary Large Cell Neuroendocrine Carcinoma: Novel Concepts and Treatments.
    Yoshimura M; Seki K; Bychkov A; Fukuoka J
    Front Oncol; 2021; 11():671799. PubMed ID: 33968782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.